Expression of CD40 ligand in CD40-positive murine tumors activates transcription of the interleukin-23 subunit genes and produces antitumor responses

Anticancer Research

Volumn 24, Issue 5 A, 2004, Pages 2713-2716

  Wada, Akihiko ^a,b   Tada, Yuji ^a,b   Shimozato, Osamu ^a   Takiguchi, Yuichi ^b   Tatsumi, Koichiro ^b   Kuriyama, Takayuki ^b   Tagawa, Masatoshi ^a  

^a CHIBA CANCER CENTER   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

CD40; CD40 ligand; IL 23

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; INTERLEUKIN 23;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; GENE EXPRESSION; GENETIC TRANSFECTION; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION INITIATION; TUMOR CELL; TUMOR GROWTH; TUMOR IMMUNITY;

ANIMALS; ANTIGENS, CD40; CARCINOMA, LEWIS LUNG; CD40 LIGAND; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; INTERLEUKIN-12; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-23; INTERLEUKIN-23 SUBUNIT P19; INTERLEUKINS; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; PROTEIN SUBUNITS; TRANSCRIPTION, GENETIC; TRANSFECTION; UP-REGULATION;

EID: 6444243682     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Tepper RI and Mulé JJ: Experimental and clinical studies of cytokine gene-modified tumor cells. Human Gene Ther 5: 153-164, 1994.
2. Tagawa M: Cytokine therapy for cancer. Curr Pharm Des 6: 681-699, 2000.
3. Banchereau J and Steinman RM: Dendritic cells and the control of immunity. Nature 392: 245-252, 1998.
4. Trinchieri G, Pflanz S and Kastelein RA: The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 19: 641-644, 2003.
5. Brombacher F, Kastelein RA and Alber G: Novel IL-12 family members shed light on the orchestration of Th1 responses. Trends Immunol 24: 207-212, 2003.
6. Tong AW and Stone MJ: Prospects for CD40-directed experimental therapy of human cancer. Cancer Gene Ther 10: 1-13, 2003.
7. Jakobson E, Jonsson G, Bjorck P and Paulie S: Stimulation of CD40 in human bladder carcinoma cells inhibits anti-Fas/APO-1 (CD95)-induced apoptosis. Int J Cancer 77: 849-853, 1998.
8. Wang YQ, Ugai S, Shimozato O, Yu L, Kawamura K, Yamamoto H, Yamaguchi T, Saisho H and Tagawa M: Induction of systemic immunity by expression of interleukin-23 in murine colon carcinoma cells. Int J Cancer 105: 820-824, 2003.
9. Lo CH, Lee SC, Wu PY, Pan WY, Su J, Cheng CW, Roffler SR, Chiang BL, Lee CN, Wu CW and Tao MH: Antitumor and antimetastatic activity of IL-23. J Immunol 171: 600-607, 2003.
10. Takasu M, Tada Y, Wang JO, Tagawa M and Takenaga K: Resistance to apoptosis induced by microenvironmental stresses is correlated with metastatic potential in Lewis lung carcinoma. Clin Exp Metastasis 17: 409-416, 1999.
11. Oppmann B, Lesley R, Blom B et al: Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13: 715-725, 2000.
12. + T cells. Immunity 16: 779-790, 2002.